Search Results - "Sandini, Lorenzo"
-
1
Use of calcium supplements and the risk of coronary heart disease in 52–62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study
Published in Maturitas (20-05-2009)“…Abstract Background To analyse prospectively the effect of calcium or calcium + D supplementation on coronary heart disease (CHD) in 52–62-year-old women…”
Get full text
Journal Article -
2
Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis
Published in Journal of rheumatology (01-10-2005)“…OBJECTIVE: The inverse relationship between the occurrence of osteoarthritis (OA) and osteoporosis is controversial. Some investigators have found higher bone…”
Get full text
Journal Article -
3
Effect of vitamin D3 and calcium on fracture risk in 65‐ to 71‐year‐old women: A population‐based 3‐year randomized, controlled trial—the OSTPRE‐FPS
Published in Journal of bone and mineral research (01-07-2010)“…Antifracture efficacy of high‐dose vitamin D (800 IU) and calcium (1000 mg) remains controversial. To determine whether daily 800 IU of vitamin D and 1000 mg…”
Get full text
Journal Article -
4
-
5
Hormone therapy protects from diabetes: the Kuopio osteoporosis risk factor and prevention study
Published in European journal of endocrinology (01-06-2009)“…ObjectivesThe purpose of this population-based prospective cohort study was to examine the effect of hormone therapy (HT) on incidence of diabetes mellitus…”
Get full text
Journal Article -
6
Protective and risk factors for allergic diseases in high-risk children at the ages of two and five years
Published in International archives of allergy and immunology (01-10-2011)“…Environmental and lifestyle factors such as breast-feeding and pets seem to affect atopic disease prevalence. We identified risk factors for allergic diseases…”
Get more information
Journal Article -
7
Deterioration in ECG parameters in Fabry females and males treated by enzyme replacement therapy either for 5 or 10 years
Published in Molecular genetics and metabolism (01-02-2018)Get full text
Journal Article -
8
Enzyme replacement therapy together with renin-angiotensin system inhibition seems to prevent kidney function decrease in most Finnish Fabry patients treated either for 5 or 10 years
Published in Molecular genetics and metabolism (01-02-2019)“…Enzyme replacement therapy (ERT) has stabilized renal function but its effect on proteinuria is inconsistent. Also nephroprotective…”
Get full text
Journal Article -
9
Agreement of self-reported estrogen use with prescription data: an analysis of women from the Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE)
Published in Menopause (New York, N.Y.) (01-03-2008)“…OBJECTIVE:Self-reported data are usually used for the evaluation of the effects of hormone therapy in population studies. We examined the agreement between…”
Get full text
Journal Article -
10
PQ-interval and QRS duration increased in Fabry patients treated by enzyme replacement therapy for 12 years
Published in Molecular genetics and metabolism (01-01-2017)Get full text
Journal Article -
11
Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65–71 years? A 3-year randomized population-based trial (OSTPRE-FPS)
Published in Maturitas (01-04-2010)“…Abstract Objective The hypothesis was that the calcium and vitamin D supplementation prevents falls at the population level.Study design: The OSTPRE-FPS was a…”
Get full text
Journal Article -
12
Enzyme replacement therapy carries for 4-7 years in Fabry disease thereafter quality of life decreases
Published in Molecular genetics and metabolism (01-02-2016)Get full text
Journal Article -
13
Enzyme replacement therapy carries for 4-7years in Fabry disease thereafter quality of life decreases
Published in Molecular genetics and metabolism (01-02-2016)Get full text
Journal Article -
14
Effect of vitamin D sub(3) and calcium on fracture risk in 65- to 71-year-old women: A population-based 3-year randomized, controlled trial-the OSTPRE-FPS
Published in Journal of bone and mineral research (01-07-2010)“…Antifracture efficacy of high-dose vitamin D (800 IU) and calcium (1000mg) remains controversial. To determine whether daily 800 IU of vitamin D and 1000mg of…”
Get full text
Journal Article -
15
-
16
Factors affecting bone loss around menopause in women without HRT: a prospective study
Published in Maturitas (25-07-2003)“…Objectives: The present study evaluated the effects of menopause and other putative bone loss modifying factors on bone mineral density (BMD) change. Methods:…”
Get full text
Journal Article -
17
Hormone replacement therapy and mortality in 52- to 70-year-old women: the Kuopio Osteoporosis Risk Factor and Prevention Study
Published in European journal of endocrinology (01-01-2006)“…Objectives: To analyze prospectively the association between hormone replacement therapy (HRT) and mortality in women before old age. Design and methods: A…”
Get full text
Journal Article -
18
Smoking May Impair the Bone Protective Effects of Nutritional Calcium: A Population‐Based Approach
Published in Journal of bone and mineral research (01-06-2003)“…Postmenopausal women were randomly selected to investigate the effects of smoking on prevention of bone loss with nutritional calcium. DXA was performed twice,…”
Get full text
Journal Article -
19
Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial--the OSTPRE-FPS
Published in Journal of bone and mineral research (01-07-2010)“…Antifracture efficacy of high-dose vitamin D (800 IU) and calcium (1000 mg) remains controversial. To determine whether daily 800 IU of vitamin D and 1000 mg…”
Get full text
Journal Article -
20
Factors associated with the use of hormone replacement therapy among older women
Published in Age and ageing (01-11-2003)Get full text
Journal Article